Jenetric Receives Undisclosed Amount in Series B Funding

JenetricJenetric GmbH announced that it has received an undisclosed amount in a Series B funding. “The whole team impressed us with their determination, with their performance and with their ambitious plans for the future. We are looking forward to accompanying the further development,” says Karin Rabe, Investment Manager of bm|t, the holding company of the Free State of Thuringia. Also the Business Angel Prof. Dr. Franz Schmidt and the early-stage investor “High-Tech Gründerfonds (HTGF)” stay financially engaged and thus enable the production and global distribution of LIVETOUCH® quattro. Dr. Ansgar Kirchheim, Investment Manager at HTGF: “After the successful FBI certification and the start of production, we are pleased to support the large-scale market entry of JENETRIC .”

Capturew

JENETRIC GmbH was founded in 2014 in Jena, Germany – a location famous for cutting-edge optical technology – by engineers with significant experience in fingerprint technology and special focus on the development of biometric systems. The multidisciplinary team includes hardware and software specialists as well as production and sales professionals. The company follows a holistic approach in its product development with a clear and strong focus on customer requirements and with the ambitious goal of enhancing living and working conditions by using biometric systems.

English Press Release